Does a sirolimus-based immunosuppression in calcineurin inhibitor-free regime improve chronic renal failure in cardiac transplant recipients independent from blood pressure?

被引:0
|
作者
Dietrich, MM
Stypmann, J
Suwelack, B
机构
[1] Univ Hosp Munster, Dept Internal Med D, Munster, Germany
[2] Univ Hosp Munster, Dept Internal Med C, Munster, Germany
关键词
heart transplant recipient; renal failure; sirolimus;
D O I
10.1016/j.amjhyper.2005.03.353
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:127A / 127A
页数:1
相关论文
共 50 条
  • [41] The effect of 2-gram versus 1-gram concentration controlled mycophenolate mofetil on renal transplant outcomes using sirolimus-based calcineurin inhibitor drug-free immunosuppression
    Flechner, SM
    Feng, L
    Mastroianni, B
    Savas, K
    Arnovitz, J
    Moneim, H
    Modlin, CS
    Goldfarb, D
    Cook, DJ
    Novick, AC
    [J]. TRANSPLANTATION, 2005, 79 (08) : 926 - 934
  • [42] Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients
    Mulgaonkar, Shamkant
    Kaufman, Dixon B.
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (11) : 1209 - 1224
  • [43] Prospective, Randomized Study of Conversion from Calcineurin Inhibitor (CNI)- to Belatacept (BELA)-Based Maintenance Immunosuppression in Renal Transplant Recipients
    Budde, K.
    Prashar, R.
    Haller, H.
    Rial, M.
    Kamar, N.
    Agarwal, A.
    de Fijter, J.
    Rostaing, L.
    Berger, S.
    Djamali, A.
    Leca, N.
    Allamassey, L.
    Gao, S.
    Polinsky, M.
    Vincenti, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 437 - 438
  • [44] Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency
    Kamar, Nassim
    Frimat, Luc
    Blancho, Gilles
    Wolff, Philippe
    Delahousse, Michel
    Rostaing, Lionel
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 (02) : 128 - 134
  • [45] Five-year follow-up after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft nephropathy
    Xia, Sheng-Qiang
    Fan, Yu
    Tan, Ming-Yue
    Zheng, Jun-Hua
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 3552 - 3558
  • [46] Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol
    Jaber, James J.
    Feustel, Paul J.
    Elbahloul, Ossama
    Conti, Alexander D.
    Gallichio, Michael H.
    Conti, David J.
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (01) : 101 - 109
  • [47] Conversion from Calcineurin Inhibitor? to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial
    Budde, Klemens
    Prashar, Rohini
    Haller, Hermann
    Rial, Maria C.
    Kamar, Nassim
    Agarwal, Avinash
    de Fijter, Johan W.
    Rostaing, Lionel
    Berger, Stefan P.
    Djamali, Arjang
    Leca, Nicolae
    Allamassey, Lisa
    Gao, Sheng
    Polinsky, Martin
    Vincenti, Flavio
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (12): : 3252 - 3264
  • [48] Conversion from Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency: Interim Safety and Efficacy Results
    Keogh, Anne
    Zuckermann, Andreas
    Crespo-Leiro, Maria G.
    Mancini, Donna
    Gonzalez-Vilchez, Francisco
    Almenar, Luis
    Brozena, Susan
    Eisen, Howard
    Tai, Sandi See
    Kushwaha, Sudhir
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 408 - 408
  • [49] Conversion From Calcineurin Inhibitor to Either Mycophenolate Mofetil or Sirolimus Improves Renal Function in Liver Transplant Recipients With Chronic Kidney Disease: Results of a Prospective Randomized Trial
    Herlenius, G.
    Felldin, M.
    Norden, G.
    Olausson, M.
    Backman, L.
    Gustafsson, B.
    Friman, S.
    [J]. TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4441 - 4448
  • [50] An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI
    Sanchez-Escuredo, Ana
    Diekmann, Fritz
    Revuelta, Ignacio
    Esforzado, Nuria
    Jose Ricart, Maria
    Cofan, Frederic
    Torregrosa, Jose-Vicente
    Peri, Lluis
    Ruiz, Angel
    Maria Campistol, Josep
    Oppenheimer, Federico
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 (03) : 362 - 368